Cancer Trials Database Comment Window Gets 30-Day Boost
Published Date: 3/10/2026
Notice
Summary
The National Cancer Institute is asking for 30 more days of public comments on their Clinical Trials Reporting Program (CTRP) database, which helps track cancer research studies. This correction fixes a previous notice and explains that no comments were received during the first 60 days. The program saves time by reducing duplicate reports, and there’s no cost except the time spent by researchers updating the database.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Annual Time Burden on Researchers
Clinical research administrators and other respondents are estimated to spend a total of 18,000 hours per year on the CTRP database. The notice lists 9,000 respondents, 24,000 annual responses, and 18,000 estimated annualized burden hours.
Per-Report Time and Frequency Requirements
The CTRP requires initial trial registration that takes 1 hour, trial registration updates that take 1 hour, trial registration amendments that take 1 hour, and accrual updates that take 30 minutes each. The notice states there are three amendments and four accrual updates per trial each year.
No Monetary Costs; Fewer Duplicate Reports
The notice says there are no costs to respondents other than their time and that the CTRP consolidates reporting to reduce redundant submissions. OMB approval is requested for three years under control number 0925-0600.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
Previous / Next Documents
Previous: 2026-04634 — Sunshine Act Meetings
The Legal Services Corporation is holding three virtual committee meetings on March 16, 18, and 19, 2026, open for public viewing on YouTube. These meetings cover updates on leadership councils, legal service delivery, and operations, with some parts possibly closed for sensitive discussions. No new costs or deadlines are introduced, but the public gets a clearer window into how legal aid is managed and improved.
Next: 2026-04636 — Certification Notice-258; Notice of Filing of Self-Certification of Coal Capability Under the Powerplant and Industrial Fuel Use Act
South Field Energy LLC has told the Department of Energy that their new power plant can use coal if needed, even though it mainly plans to use natural gas. This is required by law to make sure new power plants can switch fuels if necessary. This notice lets everyone know the plant meets the rules before it starts running, with no extra costs or delays expected.